Vassili Soumelis is the Chief Medical Officer at OWKIN, a company that specializes in using AI and machine learning to accelerate drug discovery and development in oncology and other therapeutic areas. Vassili Soumelis has researched Immune system in several fields, including Spleen, Tonsil, Antigen and Lymph. In the subject of general Cell biology, his work in Kinase is often linked to NFKB1, thereby combining diverse domains of study.